Global and United States Dermatology OTC Medications Market Insights, Forecast to 2027
SKU ID : QYR-18707691 | Publishing Date : 06-Jul-2021 | No. of pages : 155
Detailed TOC of Global and United States Dermatology OTC Medications Market Insights, Forecast to 2027
1 Study Coverage1.1 Dermatology OTC Medications Product Introduction
1.2 Market by Type
1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
1.2.2 External Use
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatology OTC Medications Market Size, Estimates and Forecasts
2.1.1 Global Dermatology OTC Medications Revenue 2016-2027
2.1.2 Global Dermatology OTC Medications Sales 2016-2027
2.2 Global Dermatology OTC Medications, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Dermatology OTC Medications Historical Market Size by Region (2016-2021)
2.3.1 Global Dermatology OTC Medications Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Dermatology OTC Medications Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Dermatology OTC Medications Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Dermatology OTC Medications Sales Forecast by Region (2022-2027)
2.4.2 Global Dermatology OTC Medications Revenue Forecast by Region (2022-2027)
3 Global Dermatology OTC Medications Competitor Landscape by Players
3.1 Global Top Dermatology OTC Medications Manufacturers by Sales
3.1.1 Global Dermatology OTC Medications Sales by Manufacturer (2016-2021)
3.1.2 Global Dermatology OTC Medications Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Dermatology OTC Medications Manufacturers by Revenue
3.2.1 Key Dermatology OTC Medications Manufacturers Covered: Ranking by Revenue
3.2.2 Global Dermatology OTC Medications Revenue by Manufacturers (2016-2021)
3.2.3 Global Dermatology OTC Medications Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Dermatology OTC Medications Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2020
3.2.6 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dermatology OTC Medications Price by Manufacturers
3.4 Global Dermatology OTC Medications Manufacturing Base Distribution, Product Types
3.4.1 Dermatology OTC Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatology OTC Medications Product Type
3.4.3 Date of International Manufacturers Enter into Dermatology OTC Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Dermatology OTC Medications Market Size by Type (2016-2021)
4.1.1 Global Dermatology OTC Medications Sales by Type (2016-2021)
4.1.2 Global Dermatology OTC Medications Revenue by Type (2016-2021)
4.1.3 Dermatology OTC Medications Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Dermatology OTC Medications Market Size Forecast by Type (2022-2027)
4.2.1 Global Dermatology OTC Medications Sales Forecast by Type (2022-2027)
4.2.2 Global Dermatology OTC Medications Revenue Forecast by Type (2022-2027)
4.2.3 Dermatology OTC Medications Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Dermatology OTC Medications Market Size by Application (2016-2021)
5.1.1 Global Dermatology OTC Medications Sales by Application (2016-2021)
5.1.2 Global Dermatology OTC Medications Revenue by Application (2016-2021)
5.1.3 Dermatology OTC Medications Price by Application (2016-2021)
5.2 Dermatology OTC Medications Market Size Forecast by Application (2022-2027)
5.2.1 Global Dermatology OTC Medications Sales Forecast by Application (2022-2027)
5.2.2 Global Dermatology OTC Medications Revenue Forecast by Application (2022-2027)
5.2.3 Global Dermatology OTC Medications Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Dermatology OTC Medications Market Size YoY Growth 2016-2027
6.1.1 United States Dermatology OTC Medications Sales YoY Growth 2016-2027
6.1.2 United States Dermatology OTC Medications Revenue YoY Growth 2016-2027
6.1.3 United States Dermatology OTC Medications Market Share in Global Market 2016-2027
6.2 United States Dermatology OTC Medications Market Size by Players (International and Local Players)
6.2.1 United States Top Dermatology OTC Medications Players by Sales (2016-2021)
6.2.2 United States Top Dermatology OTC Medications Players by Revenue (2016-2021)
6.3 United States Dermatology OTC Medications Historic Market Review by Type (2016-2021)
6.3.1 United States Dermatology OTC Medications Sales Market Share by Type (2016-2021)
6.3.2 United States Dermatology OTC Medications Revenue Market Share by Type (2016-2021)
6.3.3 United States Dermatology OTC Medications Price by Type (2016-2021)
6.4 United States Dermatology OTC Medications Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Dermatology OTC Medications Sales Forecast by Type (2022-2027)
6.4.2 United States Dermatology OTC Medications Revenue Forecast by Type (2022-2027)
6.4.3 United States Dermatology OTC Medications Price Forecast by Type (2022-2027)
6.5 United States Dermatology OTC Medications Historic Market Review by Application (2016-2021)
6.5.1 United States Dermatology OTC Medications Sales Market Share by Application (2016-2021)
6.5.2 United States Dermatology OTC Medications Revenue Market Share by Application (2016-2021)
6.5.3 United States Dermatology OTC Medications Price by Application (2016-2021)
6.6 United States Dermatology OTC Medications Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Dermatology OTC Medications Sales Forecast by Application (2022-2027)
6.6.2 United States Dermatology OTC Medications Revenue Forecast by Application (2022-2027)
6.6.3 United States Dermatology OTC Medications Price Forecast by Application (2022-2027)
7 North America
7.1 North America Dermatology OTC Medications Market Size YoY Growth 2016-2027
7.2 North America Dermatology OTC Medications Market Facts & Figures by Country
7.2.1 North America Dermatology OTC Medications Sales by Country (2016-2021)
7.2.2 North America Dermatology OTC Medications Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Dermatology OTC Medications Market Size YoY Growth 2016-2027
8.2 Asia Pacific Dermatology OTC Medications Market Facts & Figures by Region
8.2.1 Asia Pacific Dermatology OTC Medications Sales by Region (2016-2021)
8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Dermatology OTC Medications Market Size YoY Growth 2016-2027
9.2 Europe Dermatology OTC Medications Market Facts & Figures by Country
9.2.1 Europe Dermatology OTC Medications Sales by Country (2016-2021)
9.2.2 Europe Dermatology OTC Medications Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Dermatology OTC Medications Market Size YoY Growth 2016-2027
10.2 Latin America Dermatology OTC Medications Market Facts & Figures by Country
10.2.1 Latin America Dermatology OTC Medications Sales by Country (2016-2021)
10.2.2 Latin America Dermatology OTC Medications Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dermatology OTC Medications Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Dermatology OTC Medications Market Facts & Figures by Country
11.2.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021)
11.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Dermatology OTC Medications Products Offered
12.1.5 Bayer Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Dermatology OTC Medications Products Offered
12.2.5 GSK Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Dermatology OTC Medications Products Offered
12.3.5 Teva Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis Dermatology OTC Medications Products Offered
12.5.5 Novartis Recent Development
12.6 Mylan
12.6.1 Mylan Corporation Information
12.6.2 Mylan Description and Business Overview
12.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mylan Dermatology OTC Medications Products Offered
12.6.5 Mylan Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Corporation Information
12.7.2 Sun Pharmaceutical Description and Business Overview
12.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered
12.7.5 Sun Pharmaceutical Recent Development
12.8 Aurobindo
12.8.1 Aurobindo Corporation Information
12.8.2 Aurobindo Description and Business Overview
12.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aurobindo Dermatology OTC Medications Products Offered
12.8.5 Aurobindo Recent Development
12.9 Galderma
12.9.1 Galderma Corporation Information
12.9.2 Galderma Description and Business Overview
12.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Galderma Dermatology OTC Medications Products Offered
12.9.5 Galderma Recent Development
12.10 CR SANJIU
12.10.1 CR SANJIU Corporation Information
12.10.2 CR SANJIU Description and Business Overview
12.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CR SANJIU Dermatology OTC Medications Products Offered
12.10.5 CR SANJIU Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer Dermatology OTC Medications Products Offered
12.11.5 Bayer Recent Development
12.12 Lupin
12.12.1 Lupin Corporation Information
12.12.2 Lupin Description and Business Overview
12.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Lupin Products Offered
12.12.5 Lupin Recent Development
12.13 Bausch Health
12.13.1 Bausch Health Corporation Information
12.13.2 Bausch Health Description and Business Overview
12.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Bausch Health Products Offered
12.13.5 Bausch Health Recent Development
12.14 Cipla
12.14.1 Cipla Corporation Information
12.14.2 Cipla Description and Business Overview
12.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cipla Products Offered
12.14.5 Cipla Recent Development
12.15 Qilu Pharmaceutical
12.15.1 Qilu Pharmaceutical Corporation Information
12.15.2 Qilu Pharmaceutical Description and Business Overview
12.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Qilu Pharmaceutical Products Offered
12.15.5 Qilu Pharmaceutical Recent Development
12.16 Almirall
12.16.1 Almirall Corporation Information
12.16.2 Almirall Description and Business Overview
12.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Almirall Products Offered
12.16.5 Almirall Recent Development
12.17 Lingrui
12.17.1 Lingrui Corporation Information
12.17.2 Lingrui Description and Business Overview
12.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Lingrui Products Offered
12.17.5 Lingrui Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Dermatology OTC Medications Industry Trends
13.2 Dermatology OTC Medications Market Drivers
13.3 Dermatology OTC Medications Market Challenges
13.4 Dermatology OTC Medications Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatology OTC Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Dermatology OTC Medications Market Insights, Forecast to 2027
List of TablesTable 1. Global Dermatology OTC Medications Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of External Use
Table 3. Major Manufacturers of Oral
Table 4. Global Dermatology OTC Medications Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 5. Global Dermatology OTC Medications Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Dermatology OTC Medications Sales by Regions (2016-2021) & (M Units)
Table 7. Global Dermatology OTC Medications Sales Market Share by Regions (2016-2021)
Table 8. Global Dermatology OTC Medications Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Dermatology OTC Medications Sales Forecast by Region (2022-2027) & (M Units)
Table 10. Global Dermatology OTC Medications Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Dermatology OTC Medications Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Dermatology OTC Medications Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Dermatology OTC Medications Sales by Manufacturers (2016-2021) (M Units)
Table 14. Global Dermatology OTC Medications Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Dermatology OTC Medications Manufacturers by Revenue (US$ Million) in 2020
Table 16. Dermatology OTC Medications Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Dermatology OTC Medications Revenue Share by Manufacturers (2016-2021)
Table 18. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Medications as of 2020)
Table 20. Key Manufacturers Dermatology OTC Medications Price (2016-2021) (USD/Unit)
Table 21. Dermatology OTC Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dermatology OTC Medications Product Type
Table 23. Date of International Manufacturers Enter into Dermatology OTC Medications Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Dermatology OTC Medications Sales by Type (2016-2021) (M Units)
Table 26. Global Dermatology OTC Medications Sales Share by Type (2016-2021)
Table 27. Global Dermatology OTC Medications Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Dermatology OTC Medications Revenue Share by Type (2016-2021)
Table 29. Dermatology OTC Medications Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Dermatology OTC Medications Sales Forecast by Type (2022-2027) & (M Units)
Table 31. Global Dermatology OTC Medications Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Dermatology OTC Medications Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Dermatology OTC Medications Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Dermatology OTC Medications Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Dermatology OTC Medications Sales by Application (2016-2021) (M Units)
Table 36. Global Dermatology OTC Medications Sales Share by Application (2016-2021)
Table 37. Global Dermatology OTC Medications Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Dermatology OTC Medications Revenue Share by Application (2016-2021)
Table 39. Dermatology OTC Medications Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Dermatology OTC Medications Sales Forecast by Application (2022-2027) & (M Units)
Table 41. Global Dermatology OTC Medications Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Dermatology OTC Medications Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Dermatology OTC Medications Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Dermatology OTC Medications Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. United States Dermatology OTC Medications Sales (M Units) of Key Companies (2016-2021)
Table 46. United States Dermatology OTC Medications Sales Share by Company (2016-2021)
Table 47. United States Dermatology OTC Medications Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Dermatology OTC Medications Revenue Share by Company (2016-2021)
Table 49. United States Dermatology OTC Medications Sales (M Units) by Type (2016-2021)
Table 50. United States Dermatology OTC Medications Sales Share by Type (2016-2021)
Table 51. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Dermatology OTC Medications Price (USD/Unit) by Type (2016-2021)
Table 53. United States Dermatology OTC Medications Sales (M Units) by Type (2022-2027)
Table 54. United States Dermatology OTC Medications Sales Share by Type (2022-2027)
Table 55. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Dermatology OTC Medications Revenue Share by Type (2022-2027)
Table 57. United States Dermatology OTC Medications Price (USD/Unit) by Type (2022-2027)
Table 58. United States Dermatology OTC Medications Sales (M Units) by Application (2016-2021)
Table 59. United States Dermatology OTC Medications Sales Share by Application (2016-2021)
Table 60. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Dermatology OTC Medications Price (USD/Unit) by Application (2016-2021)
Table 62. United States Dermatology OTC Medications Sales (M Units) by Application (2022-2027)
Table 63. United States Dermatology OTC Medications Sales Share by Application (2022-2027)
Table 64. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Dermatology OTC Medications Revenue Share by Application (2022-2027)
Table 66. United States Dermatology OTC Medications Price (USD/Unit) by Application (2022-2027)
Table 67. North America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 68. North America Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 69. North America Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
Table 72. Asia Pacific Dermatology OTC Medications Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Dermatology OTC Medications Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Dermatology OTC Medications Revenue Market Share by Region (2016-2021)
Table 75. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 76. Europe Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 77. Europe Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 79. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 80. Latin America Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 84. Middle East and Africa Dermatology OTC Medications Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country (2016-2021)
Table 87. Bayer Corporation Information
Table 88. Bayer Description and Business Overview
Table 89. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Bayer Dermatology OTC Medications Product
Table 91. Bayer Recent Development
Table 92. GSK Corporation Information
Table 93. GSK Description and Business Overview
Table 94. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. GSK Product
Table 96. GSK Recent Development
Table 97. Teva Corporation Information
Table 98. Teva Description and Business Overview
Table 99. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Teva Product
Table 101. Teva Recent Development
Table 102. Johnson & Johnson Corporation Information
Table 103. Johnson & Johnson Description and Business Overview
Table 104. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Johnson & Johnson Product
Table 106. Johnson & Johnson Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Business Overview
Table 109. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Mylan Corporation Information
Table 113. Mylan Description and Business Overview
Table 114. Mylan Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Mylan Product
Table 116. Mylan Recent Development
Table 117. Sun Pharmaceutical Corporation Information
Table 118. Sun Pharmaceutical Description and Business Overview
Table 119. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Sun Pharmaceutical Product
Table 121. Sun Pharmaceutical Recent Development
Table 122. Aurobindo Corporation Information
Table 123. Aurobindo Description and Business Overview
Table 124. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Aurobindo Product
Table 126. Aurobindo Recent Development
Table 127. Galderma Corporation Information
Table 128. Galderma Description and Business Overview
Table 129. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Galderma Product
Table 131. Galderma Recent Development
Table 132. CR SANJIU Corporation Information
Table 133. CR SANJIU Description and Business Overview
Table 134. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. CR SANJIU Product
Table 136. CR SANJIU Recent Development
Table 137. Dr. Reddy's Corporation Information
Table 138. Dr. Reddy's Description and Business Overview
Table 139. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Dr. Reddy's Product
Table 141. Dr. Reddy's Recent Development
Table 142. Lupin Corporation Information
Table 143. Lupin Description and Business Overview
Table 144. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Lupin Product
Table 146. Lupin Recent Development
Table 147. Bausch Health Corporation Information
Table 148. Bausch Health Description and Business Overview
Table 149. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Bausch Health Product
Table 151. Bausch Health Recent Development
Table 152. Cipla Corporation Information
Table 153. Cipla Description and Business Overview
Table 154. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Cipla Product
Table 156. Cipla Recent Development
Table 157. Qilu Pharmaceutical Corporation Information
Table 158. Qilu Pharmaceutical Description and Business Overview
Table 159. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Qilu Pharmaceutical Product
Table 161. Qilu Pharmaceutical Recent Development
Table 162. Almirall Corporation Information
Table 163. Almirall Description and Business Overview
Table 164. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 165. Almirall Product
Table 166. Almirall Recent Development
Table 167. Lingrui Corporation Information
Table 168. Lingrui Description and Business Overview
Table 169. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 170. Lingrui Product
Table 171. Lingrui Recent Development
Table 172. Dermatology OTC Medications Market Trends
Table 173. Dermatology OTC Medications Market Drivers
Table 174. Dermatology OTC Medications Market Challenges
Table 175. Dermatology OTC Medications Market Restraints
Table 176. Dermatology OTC Medications Customers List
Table 177. Dermatology OTC Medications Distributors List
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology OTC Medications Product Picture
Figure 2. Global Dermatology OTC Medications Sales Market Share by Type in 2020 & 2027
Figure 3. External Use Product Picture
Figure 4. Oral Product Picture
Figure 5. Global Dermatology OTC Medications Sales Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Other
Figure 9. Dermatology OTC Medications Report Years Considered
Figure 10. Global Dermatology OTC Medications Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dermatology OTC Medications Market Size 2016-2027 (US$ Million)
Figure 12. Global Dermatology OTC Medications Sales 2016-2027 (M Units)
Figure 13. Global Dermatology OTC Medications Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Dermatology OTC Medications Sales Market Share by Region (2016-2021)
Figure 15. Global Dermatology OTC Medications Sales Market Share by Region in 2020
Figure 16. Global Dermatology OTC Medications Revenue Market Share by Region (2016-2021)
Figure 17. Global Dermatology OTC Medications Revenue Market Share by Region in 2020
Figure 18. Global Dermatology OTC Medications Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Dermatology OTC Medications Revenue in 2020
Figure 20. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Dermatology OTC Medications Sales Market Share by Type (2016-2021)
Figure 22. Global Dermatology OTC Medications Sales Market Share by Type in 2020
Figure 23. Global Dermatology OTC Medications Revenue Market Share by Type (2016-2021)
Figure 24. Global Dermatology OTC Medications Revenue Market Share by Type in 2020
Figure 25. Global Dermatology OTC Medications Sales Market Share by Application (2016-2021)
Figure 26. Global Dermatology OTC Medications Sales Market Share by Application in 2020
Figure 27. Global Dermatology OTC Medications Revenue Market Share by Application (2016-2021)
Figure 28. Global Dermatology OTC Medications Revenue Market Share by Application in 2020
Figure 29. United States Dermatology OTC Medications Sales Growth Rate 2016-2027 (M Units)
Figure 30. United States Dermatology OTC Medications Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Dermatology OTC Medications Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Dermatology OTC Medications Players Market Share by Revenue in Dermatology OTC Medications in 2020
Figure 33. United States Dermatology OTC Medications Revenue Share by Type (2016-2021)
Figure 34. United States Dermatology OTC Medications Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Dermatology OTC Medications Revenue Share by Application (2016-2021)
Figure 36. United States Dermatology OTC Medications Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units)
Figure 38. North America Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 40. North America Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 41. U.S. Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 42. U.S. Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 44. Canada Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units)
Figure 46. Europe Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 48. Europe Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 49. Germany Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 50. Germany Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 52. France Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 54. U.K. Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 56. Italy Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 58. Russia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units)
Figure 60. Asia Pacific Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Dermatology OTC Medications Sales Market Share by Region in 2020
Figure 62. Asia Pacific Dermatology OTC Medications Revenue Market Share by Region in 2020
Figure 63. China Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 64. China Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 66. Japan Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 68. South Korea Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 70. India Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 72. Australia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 74. Taiwan Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 76. Indonesia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 78. Thailand Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 80. Malaysia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 82. Philippines Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 84. Vietnam Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units)
Figure 86. Latin America Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 88. Latin America Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 89. Mexico Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 90. Mexico Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 92. Brazil Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 94. Argentina Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units)
Figure 96. Middle East and Africa Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Dermatology OTC Medications Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country in 2020
Figure 99. Turkey Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 100. Turkey Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 102. Saudi Arabia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units)
Figure 104. UAE Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Dermatology OTC Medications Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
Keyplayers in Global and United States Dermatology OTC Medications Market Insights, Forecast to 2027
BayerGSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui